11 | P a g e
this reason, FDA helped develop a detailed test method to measure EMI of
implanted cardiac pacemakers and defibrillators from cell phones. This test
method is now part of a standard sponsored by the Association for the
Advancement of Medical Instrumentation (AAMI). This standard will allow
manufacturers to ensure that cardiac pacemakers and defibrillators are safe from
cell phone EMI.
The FDA continues to monitor the use of cell phones for possible interactions with
other medical devices. Should harmful interference be found to occur, FDA will
conduct testing to assess the interference and work to resolve the problem.
For more information reference sources for pacemakers can be found at U.S.
Food and Drug Administration web site: www.fda.gov , see Radiation-Emitting
Products and procedures, Interference with Pacemakers and Other Medical
Devices
-----------------------------------------------------------------------
Except as permitted under the relevant local legislation, no part of this publication
may be copied, transmitted, transcribed, or distributed in any form or by any
means, or stored in a database or retrieval system, or translated in any language
(natural or computer), without the prior written permission of CPI.
CPI reserves the right to change the product or the product specifications at any
time. While every effort has been made to ensure that the information in this
publication is accurate, CPI disclaims any liability for any direct or indirect losses
(howsoever caused) arising out of use or reliance on this information. This
document does not necessarily imply product availability. Note: Your product may
differ slightly from some of the illustrations in this document.
CPI Corporate Headquarters
3222 Phoenixville Pike Suite 200
Malvern, PA 19355
www.CranePI.com
For Technical Support, call:
1-800-628-8363 or visit:
www.CranePI.com/Support